Antibodies 50% gone by six months, 75% by a year.
Also highly seasonal, for what it's worth. Only 10 patients, all in the Netherlands, but a long study period.
Antibodies 50% gone by six months, 75% by a year.
Also highly seasonal, for what it's worth. Only 10 patients, all in the Netherlands, but a long study period.
"They found that people frequently got reinfected with the same coronavirus, even in the same year, and sometimes more than once. Over a year and a half, a dozen of the volunteers tested positive two or three times for the same virus, in one case with just four weeks between positive results."
However, if you get antibodies from somebody who had COVID-19, then it does not confer you immunity. Those antibodies do not give your body a memory effect that allows your body, on its own, to respond to the infection as a preventative measure for COVID-19.
What it does though, for people who are actively infected with COVID-19, is reduce the severity of the infection. The influx of antibodies are believed to "neutralize" the COVID-19 virus already present in the body, by binding to the virus itself.
This means the disease will be much less contagious, and join the corpus of all other viruses out there that can cause serious disease, but it will be rare. For most people it will just be another variant of the common cold.
The vaccine will also be included in the annual vaccine cocktail for the elderly. So they will be immune. Since elderly account for 90%+ of deaths the disease will then be much less scary with <0.01% mortality (which is higher than say, driving a car to work).
Encouragingly, there seems to be a degree of cross-immunity between HCOV’s. This paper touches on the possible implications: https://science.sciencemag.org/content/368/6493/860
The vaccine will be interesting to see. There's a fair chance it will confer some immunity, but that those infected will may get a little sick.